TIS 0.00% 0.0¢ tissue therapies limited

competition?, page-3

  1. 1,858 Posts.
    Looking at the results for Woulgan Biogel presented at a seminar last month, the product doesn't seem to come close to VG. See p6 of

    http://www.newsweb.no/newsweb/attachment.do?name=Carnegie_Stockholm_2012.pdf&attId=103275

    By comparison, VG was effective on wounds that hadn't responded to standard treatment.

    Interesting about the CE filing though.

    "Submitted dossier for CE mark as an advanced medical device (Class III, Rule 13)...Approval expected by the end of first half 2013"

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.